- ►ahajournals.org W Ageno, C Becattini, T Brighton, R Selby, … - Circulation, 2008 - Am Heart Assoc Methods and Results— Medline and EMBASE databases were searched to identify
studies that evaluated the prevalence of major cardiovascular risk factors in
VTE patients and control subjects. Studies were selected using a priori ... Cited by 65 - Related articles - All 9 versions
CH Wang, MK Ting, S Verma, LT Kuo, NI Yang … - American heart journal, 2006 - Elsevier After pioglitazone treatment, the numbers of circulating EPCs significantly
increased (from 0.44% ± 0.14% to 0.89% ± 0.29%, P = .01). The migratory
response and the adhesive capacity to fibronectin and collagen were ... Cited by 53 - Related articles - All 14 versions
EA Podrez, TV Byzova, M Febbraio, RG Salomon … - Nature - lmp.facmed.utoronto.ca Dyslipidemia is associated with a prothrombotic phenotype; however, the
mechanisms responsible for enhanced platelet reactivity remain unclear.
Proatherosclerotic lipid abnormalities are associated with both enhanced ... Cited by 51 - Related articles - View as HTML - BL Direct - All 7 versions
- ►pasteur.ac.ir [PDF] M Nieuwdorp, ESG Stroes, JCM Meijers, H … - Current Opinion in Pharmacology, 2005 - Elsevier The metabolic syndrome is characterized by a combination of obesity, chronic
inflammation and insulin resistance. This syndrome also has features of a
hypercoagulable state, consisting of increased levels of clotting factors ( ... Cited by 47 - Related articles - All 4 versions
- ►nih.gov M Febbraio, RL Silverstein - International Journal of Biochemistry and Cell Biology, 2007 - Elsevier CD36 is a broadly expressed membrane glycoprotein that acts as a facilitator of
fatty acid uptake, a signaling molecule, and a receptor for a wide range of
ligands, including apoptotic cells, modified forms of low density ... Cited by 42 - Related articles - All 3 versions
AI Kakafika, EN Liberopoulos, A Karagiannis, … - Current Vascular Pharmacology, 2006 - ingentaconnect.com INTRODUCTION The metabolic syndrome (MetS) is a worldwide epi- demic, setting
the stage for type 2 diabetes and its microvas- cular complications and for an
increased risk for macrovas- cular disease [1]. The prevalence of the MetS ... Cited by 28 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org H Koga, S Sugiyama, K Kugiyama, H … - European heart journal, 2006 - Eur Soc Cardiology Methods and results We measured fasting serum levels of remnant-like lipoprotein
particles-cholesterol (RLP-cholesterol) and assessed in vivo platelet activation
by quantifying the number of PMP in the plasma detected as CD42b-positive ... Cited by 22 - Related articles - BL Direct - All 4 versions
PG Northup, V Sundaram, MB Fallon, KR … - Journal of Thrombosis and Haemostasis, 2008 - ingentaconnect.com A complex balance exists between endogenous procoagulants and the anticoagulant
system in liver disease patients. Hypercoagulable events occur in cirrhosis
patients despite the well-known bleeding diathesis of liver disease. These ... Cited by 14 - Related articles - BL Direct - All 2 versions
- ►jlr.org S Ibrahim, A Djimet-Baboun, V Pruneta- … - The Journal of Lipid Research, 2006 - ASBMB LDL-associated phospholipids (PLs) may be transferred into platelets. In this
work, we characterized the role of VLDLs as PL donors. VLDL transferred
radiolabeled PLs to platelets in a temperature- and concentration-dependent ... Cited by 11 - Related articles - BL Direct - All 6 versions
F Dentali, E Romualdi, W Ageno - Haematologica, 2007 - haematologica.com Recent studies from Europe reported that the prevalence of the metabolic
syndrome ranges between 5 and 20% in the adult population, according to the
different definitions used. 6–8 Affected patients have a significantly ... Cited by 7 - Related articles - BL Direct - All 11 versions
